Susquehanna International Group’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $169K | Buy |
|
|||||
|
2025
Q2 | $116K | Sell |
|
|||||
|
2025
Q1 | $172K | Buy |
|
|||||
|
2024
Q4 | $40.2K | Buy |
|
|||||
|
2024
Q3 | $42.3K | Sell |
|
|||||
|
2024
Q2 | $301K | Sell |
|
|||||
|
2024
Q1 | $762K | Buy |
|
|||||
|
2023
Q4 | $310K | Sell |
|
|||||
|
2023
Q3 | $439K | Buy |
|
|||||
|
2023
Q2 | $498K | Sell |
|
|||||
|
2023
Q1 | $2.31M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Buy |
|
|||||
|
2022
Q3 | $90K | Sell |
|
|||||
|
2022
Q2 | $269K | Buy |
|
|||||
|
2022
Q1 | $181K | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $174K | Buy |
|
|||||
|
2021
Q1 | $149K | Sell |
|
|||||
|
2020
Q4 | $372K | Buy |
|
|||||
|
2020
Q3 | $193K | Buy |
|
|||||
|
2020
Q2 | $41K | Buy |
|
|||||
|
2020
Q1 | $12K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3K | Sell |
|
|||||
|
2019
Q2 | $17K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $36K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $29K | Buy |
|
|||||
|
2016
Q3 | $37K | Buy |
|
|||||
|
2016
Q2 | $37K | Sell |
|
|||||
|
2016
Q1 | $64K | Sell |
|
|||||
|
2015
Q4 | $175K | Sell |
|
|||||
|
2015
Q3 | $123K | Buy |
|
|||||
|
2015
Q2 | $159K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|